BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19883951)

  • 1. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.
    Bhide SA; Gulliford S; Kazi R; El-Hariry I; Newbold K; Harrington KJ; Nutting CM
    Radiother Oncol; 2009 Dec; 93(3):539-44. PubMed ID: 19883951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
    Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
    Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
    Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
    BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
    Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
    Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.
    Mazzola R; Ricchetti F; Fiorentino A; Fersino S; Giaj Levra N; Naccarato S; Sicignano G; Albanese S; Di Paola G; Alterio D; Ruggieri R; Alongi F
    Br J Radiol; 2014 Dec; 87(1044):20140543. PubMed ID: 25348370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.
    Deantonio L; Masini L; Brambilla M; Pia F; Krengli M
    Strahlenther Onkol; 2013 Mar; 189(3):230-6. PubMed ID: 23319255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
    Nutting C; Finneran L; Roe J; Sydenham MA; Beasley M; Bhide S; Boon C; Cook A; De Winton E; Emson M; Foran B; Frogley R; Petkar I; Pettit L; Rooney K; Roques T; Srinivasan D; Tyler J; Hall E;
    Lancet Oncol; 2023 Aug; 24(8):868-880. PubMed ID: 37423227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
    Eisbruch A; Schwartz M; Rasch C; Vineberg K; Damen E; Van As CJ; Marsh R; Pameijer FA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1425-39. PubMed ID: 15590174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharyngeal Constrictor Dose-Volume Histogram Metrics and Patient-Reported Dysphagia in Head and Neck Radiotherapy.
    Paetkau O; Weppler S; Kwok J; Quon HC; Gomes da Rocha C; Smith W; Tchistiakova E; Kirkby C
    Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):173-182. PubMed ID: 38220581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Changes in Pharyngeal Constrictor Muscles Related to Head and Neck Radiotherapy: A Systematic Review.
    Grepl J; Sirak I; Vosmik M; Tichy A
    Technol Cancer Res Treat; 2020; 19():1533033820945805. PubMed ID: 32734851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
    Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
    Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
    Bhide SA; Gulliford S; Fowler J; Rosenfelder N; Newbold K; Harrington KJ; Nutting CM
    Radiother Oncol; 2010 Oct; 97(1):86-91. PubMed ID: 20826031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
    Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
    Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
    Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.
    van der Molen L; Heemsbergen WD; de Jong R; van Rossum MA; Smeele LE; Rasch CR; Hilgers FJ
    Radiother Oncol; 2013 Mar; 106(3):364-9. PubMed ID: 23540551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
    Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
    Messer JA; Mohamed AS; Hutcheson KA; Ding Y; Lewin JS; Wang J; Lai SY; Frank SJ; Garden AS; Sandulache V; Eichelberger H; French CC; Colen RR; Phan J; Kalpathy-Cramer J; Hazle JD; Rosenthal DI; Gunn GB; Fuller CD
    Radiother Oncol; 2016 Feb; 118(2):315-22. PubMed ID: 26830697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.
    Batham S; Gupta S; Ghosh A; Gupta IJ; Johny D; Srivastava S; Singh N; Bhatt M; Gupta R; Bhosale VV; Negi M
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3697-3704. PubMed ID: 38019227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
    Bhide SA; Gulliford S; Schick U; Miah A; Zaidi S; Newbold K; Nutting CM; Harrington KJ
    Radiother Oncol; 2012 Apr; 103(1):88-91. PubMed ID: 22280809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.